Myung In Pharmaceutical LTD. (KRX:317450)

South Korea · Delayed Price · Currency is KRW

58,400

-1,100 (-1.85%)

At close: Mar 19, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Pharmaceutical	266.42B	239.42B	223.25B	207.85B	187.84B
Pharmaceutical Growth	11.28%	7.24%	7.41%	10.65%	4.27%
Real Estate Rental	3.16B	3.08B	2.77B	1.60B	33.67M
Real Estate Rental Growth	2.74%	11.01%	73.00%	4661.04%	-97.95%
Advertising Agency	4.74B	3.30B	2.66B	3.37B	3.53B
Advertising Agency Growth	43.55%	24.04%	-21.05%	-4.67%	35.84%
Consolidation Adjustment	-4.89B	-3.46B	-2.85B	-3.57B	-3.57B
Total	269.43B	242.34B	225.83B	209.25B	187.84B
Total Growth	11.18%	7.31%	7.92%	11.40%	3.33%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
South Korea	269.43B	242.34B	225.83B	209.25B	187.84B
South Korea Growth	11.18%	7.31%	7.92%	11.40%	3.33%
Total	269.43B	242.34B	225.83B	209.25B	187.84B
Total Growth	11.18%	7.31%	7.92%	11.40%	3.33%

Source: S&P Global Market Intelligence.